ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Renal Insufficiency Treatment Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-26R13877
Home | Market Reports | Health| Health Conditions
Global Renal Insufficiency Treatment Market Research Report 2023
BUY CHAPTERS

Global Renal Insufficiency Treatment Market Research Report 2025

Code: QYRE-Auto-26R13877
Report
May 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
NIKKISO
Fresenius
Baxter
Nipro
B. Braun
Medtronic Inc
Astrazeneca plc
JMS Co Ltd
Cantel Medical
Asahi Kasei Medical Co., Ltd.
Braun Melsungen AG
DaVita
Becton Dickinson and Company
Isopure Corp
Diaverum
dialifegroup

Renal Insufficiency Treatment Market Size

The global market for Renal Insufficiency Treatment was valued at US$ 14150 million in the year 2024 and is projected to reach a revised size of US$ 26980 million by 2031, growing at a CAGR of 9.8% during the forecast period.

Renal Insufficiency Treatment Market

Renal Insufficiency Treatment Market

Renal insufficiency refers to the decline of glomerular filtration rate caused by various reasons, resulting in the retention of metabolites, a clinical syndrome manifested by disturbance of water, electrolyte and acid-base balance and various systemic symptoms.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Renal Insufficiency Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Renal Insufficiency Treatment.
The Renal Insufficiency Treatment market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Renal Insufficiency Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Renal Insufficiency Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Renal Insufficiency Treatment Market Report

Report Metric Details
Report Name Renal Insufficiency Treatment Market
Accounted market size in year US$ 14150 million
Forecasted market size in 2031 US$ 26980 million
CAGR 9.8%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Clinics
  • Research and Academic Institutes
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Nikkiso, Fresenius, Baxter, Nipro, B. Braun, Medtronic, AstraZeneca, JMS Co. Ltd., Cantel Medical, Asahi Kasei Medical Co., Ltd., Braun Melsungen AG, DaVita, Becton Dickinson and Company, dialifegroup, Isopure Corp, Diaverum
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Renal Insufficiency Treatment company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Renal Insufficiency Treatment Market growing?

Ans: The Renal Insufficiency Treatment Market witnessing a CAGR of 9.8% during the forecast period 2025-2031.

What is the Renal Insufficiency Treatment Market size in 2031?

Ans: The Renal Insufficiency Treatment Market size in 2031 will be US$ 26980 million.

Who are the main players in the Renal Insufficiency Treatment Market report?

Ans: The main players in the Renal Insufficiency Treatment Market are Nikkiso, Fresenius, Baxter, Nipro, B. Braun, Medtronic, AstraZeneca, JMS Co. Ltd., Cantel Medical, Asahi Kasei Medical Co., Ltd., Braun Melsungen AG, DaVita, Becton Dickinson and Company, dialifegroup, Isopure Corp, Diaverum

What are the Application segmentation covered in the Renal Insufficiency Treatment Market report?

Ans: The Applications covered in the Renal Insufficiency Treatment Market report are Hospital, Clinics, Research and Academic Institutes

What are the Type segmentation covered in the Renal Insufficiency Treatment Market report?

Ans: The Types covered in the Renal Insufficiency Treatment Market report are Dialysis, Medication, Kidney Transplantation

Recommended Reports

Renal & Urinary Disease

Urinary Disorders

Related Systems Therapies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Renal Insufficiency Treatment Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Dialysis
1.2.3 Medication
1.2.4 Kidney Transplantation
1.3 Market by Application
1.3.1 Global Renal Insufficiency Treatment Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinics
1.3.4 Research and Academic Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Renal Insufficiency Treatment Market Perspective (2020-2031)
2.2 Global Renal Insufficiency Treatment Growth Trends by Region
2.2.1 Global Renal Insufficiency Treatment Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Renal Insufficiency Treatment Historic Market Size by Region (2020-2025)
2.2.3 Renal Insufficiency Treatment Forecasted Market Size by Region (2026-2031)
2.3 Renal Insufficiency Treatment Market Dynamics
2.3.1 Renal Insufficiency Treatment Industry Trends
2.3.2 Renal Insufficiency Treatment Market Drivers
2.3.3 Renal Insufficiency Treatment Market Challenges
2.3.4 Renal Insufficiency Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Renal Insufficiency Treatment Players by Revenue
3.1.1 Global Top Renal Insufficiency Treatment Players by Revenue (2020-2025)
3.1.2 Global Renal Insufficiency Treatment Revenue Market Share by Players (2020-2025)
3.2 Global Renal Insufficiency Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Renal Insufficiency Treatment Revenue
3.4 Global Renal Insufficiency Treatment Market Concentration Ratio
3.4.1 Global Renal Insufficiency Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Renal Insufficiency Treatment Revenue in 2024
3.5 Global Key Players of Renal Insufficiency Treatment Head office and Area Served
3.6 Global Key Players of Renal Insufficiency Treatment, Product and Application
3.7 Global Key Players of Renal Insufficiency Treatment, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Renal Insufficiency Treatment Breakdown Data by Type
4.1 Global Renal Insufficiency Treatment Historic Market Size by Type (2020-2025)
4.2 Global Renal Insufficiency Treatment Forecasted Market Size by Type (2026-2031)
5 Renal Insufficiency Treatment Breakdown Data by Application
5.1 Global Renal Insufficiency Treatment Historic Market Size by Application (2020-2025)
5.2 Global Renal Insufficiency Treatment Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Renal Insufficiency Treatment Market Size (2020-2031)
6.2 North America Renal Insufficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Renal Insufficiency Treatment Market Size by Country (2020-2025)
6.4 North America Renal Insufficiency Treatment Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Renal Insufficiency Treatment Market Size (2020-2031)
7.2 Europe Renal Insufficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Renal Insufficiency Treatment Market Size by Country (2020-2025)
7.4 Europe Renal Insufficiency Treatment Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Renal Insufficiency Treatment Market Size (2020-2031)
8.2 Asia-Pacific Renal Insufficiency Treatment Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Renal Insufficiency Treatment Market Size by Region (2020-2025)
8.4 Asia-Pacific Renal Insufficiency Treatment Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Renal Insufficiency Treatment Market Size (2020-2031)
9.2 Latin America Renal Insufficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Renal Insufficiency Treatment Market Size by Country (2020-2025)
9.4 Latin America Renal Insufficiency Treatment Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Renal Insufficiency Treatment Market Size (2020-2031)
10.2 Middle East & Africa Renal Insufficiency Treatment Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Renal Insufficiency Treatment Market Size by Country (2020-2025)
10.4 Middle East & Africa Renal Insufficiency Treatment Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Nikkiso
11.1.1 Nikkiso Company Details
11.1.2 Nikkiso Business Overview
11.1.3 Nikkiso Renal Insufficiency Treatment Introduction
11.1.4 Nikkiso Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.1.5 Nikkiso Recent Development
11.2 Fresenius
11.2.1 Fresenius Company Details
11.2.2 Fresenius Business Overview
11.2.3 Fresenius Renal Insufficiency Treatment Introduction
11.2.4 Fresenius Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.2.5 Fresenius Recent Development
11.3 Baxter
11.3.1 Baxter Company Details
11.3.2 Baxter Business Overview
11.3.3 Baxter Renal Insufficiency Treatment Introduction
11.3.4 Baxter Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.3.5 Baxter Recent Development
11.4 Nipro
11.4.1 Nipro Company Details
11.4.2 Nipro Business Overview
11.4.3 Nipro Renal Insufficiency Treatment Introduction
11.4.4 Nipro Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.4.5 Nipro Recent Development
11.5 B. Braun
11.5.1 B. Braun Company Details
11.5.2 B. Braun Business Overview
11.5.3 B. Braun Renal Insufficiency Treatment Introduction
11.5.4 B. Braun Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.5.5 B. Braun Recent Development
11.6 Medtronic
11.6.1 Medtronic Company Details
11.6.2 Medtronic Business Overview
11.6.3 Medtronic Renal Insufficiency Treatment Introduction
11.6.4 Medtronic Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.6.5 Medtronic Recent Development
11.7 AstraZeneca
11.7.1 AstraZeneca Company Details
11.7.2 AstraZeneca Business Overview
11.7.3 AstraZeneca Renal Insufficiency Treatment Introduction
11.7.4 AstraZeneca Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.7.5 AstraZeneca Recent Development
11.8 JMS Co. Ltd.
11.8.1 JMS Co. Ltd. Company Details
11.8.2 JMS Co. Ltd. Business Overview
11.8.3 JMS Co. Ltd. Renal Insufficiency Treatment Introduction
11.8.4 JMS Co. Ltd. Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.8.5 JMS Co. Ltd. Recent Development
11.9 Cantel Medical
11.9.1 Cantel Medical Company Details
11.9.2 Cantel Medical Business Overview
11.9.3 Cantel Medical Renal Insufficiency Treatment Introduction
11.9.4 Cantel Medical Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.9.5 Cantel Medical Recent Development
11.10 Asahi Kasei Medical Co., Ltd.
11.10.1 Asahi Kasei Medical Co., Ltd. Company Details
11.10.2 Asahi Kasei Medical Co., Ltd. Business Overview
11.10.3 Asahi Kasei Medical Co., Ltd. Renal Insufficiency Treatment Introduction
11.10.4 Asahi Kasei Medical Co., Ltd. Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.10.5 Asahi Kasei Medical Co., Ltd. Recent Development
11.11 Braun Melsungen AG
11.11.1 Braun Melsungen AG Company Details
11.11.2 Braun Melsungen AG Business Overview
11.11.3 Braun Melsungen AG Renal Insufficiency Treatment Introduction
11.11.4 Braun Melsungen AG Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.11.5 Braun Melsungen AG Recent Development
11.12 DaVita
11.12.1 DaVita Company Details
11.12.2 DaVita Business Overview
11.12.3 DaVita Renal Insufficiency Treatment Introduction
11.12.4 DaVita Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.12.5 DaVita Recent Development
11.13 Becton Dickinson and Company
11.13.1 Becton Dickinson and Company Company Details
11.13.2 Becton Dickinson and Company Business Overview
11.13.3 Becton Dickinson and Company Renal Insufficiency Treatment Introduction
11.13.4 Becton Dickinson and Company Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.13.5 Becton Dickinson and Company Recent Development
11.14 dialifegroup
11.14.1 dialifegroup Company Details
11.14.2 dialifegroup Business Overview
11.14.3 dialifegroup Renal Insufficiency Treatment Introduction
11.14.4 dialifegroup Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.14.5 dialifegroup Recent Development
11.15 Isopure Corp
11.15.1 Isopure Corp Company Details
11.15.2 Isopure Corp Business Overview
11.15.3 Isopure Corp Renal Insufficiency Treatment Introduction
11.15.4 Isopure Corp Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.15.5 Isopure Corp Recent Development
11.16 Diaverum
11.16.1 Diaverum Company Details
11.16.2 Diaverum Business Overview
11.16.3 Diaverum Renal Insufficiency Treatment Introduction
11.16.4 Diaverum Revenue in Renal Insufficiency Treatment Business (2020-2025)
11.16.5 Diaverum Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
NIKKISO
Fresenius
Baxter
Nipro
B. Braun
Medtronic Inc
Astrazeneca plc
JMS Co Ltd
Cantel Medical
Asahi Kasei Medical Co., Ltd.
Braun Melsungen AG
DaVita
Becton Dickinson and Company
Isopure Corp
Diaverum
dialifegroup
List of Tables
 Table 1. Global Renal Insufficiency Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Dialysis
 Table 3. Key Players of Medication
 Table 4. Key Players of Kidney Transplantation
 Table 5. Global Renal Insufficiency Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Renal Insufficiency Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Renal Insufficiency Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Renal Insufficiency Treatment Market Share by Region (2020-2025)
 Table 9. Global Renal Insufficiency Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Renal Insufficiency Treatment Market Share by Region (2026-2031)
 Table 11. Renal Insufficiency Treatment Market Trends
 Table 12. Renal Insufficiency Treatment Market Drivers
 Table 13. Renal Insufficiency Treatment Market Challenges
 Table 14. Renal Insufficiency Treatment Market Restraints
 Table 15. Global Renal Insufficiency Treatment Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Renal Insufficiency Treatment Market Share by Players (2020-2025)
 Table 17. Global Top Renal Insufficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Insufficiency Treatment as of 2024)
 Table 18. Ranking of Global Top Renal Insufficiency Treatment Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Renal Insufficiency Treatment Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Renal Insufficiency Treatment, Headquarters and Area Served
 Table 21. Global Key Players of Renal Insufficiency Treatment, Product and Application
 Table 22. Global Key Players of Renal Insufficiency Treatment, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Renal Insufficiency Treatment Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Renal Insufficiency Treatment Revenue Market Share by Type (2020-2025)
 Table 26. Global Renal Insufficiency Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Renal Insufficiency Treatment Revenue Market Share by Type (2026-2031)
 Table 28. Global Renal Insufficiency Treatment Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Renal Insufficiency Treatment Revenue Market Share by Application (2020-2025)
 Table 30. Global Renal Insufficiency Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Renal Insufficiency Treatment Revenue Market Share by Application (2026-2031)
 Table 32. North America Renal Insufficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Renal Insufficiency Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Renal Insufficiency Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Renal Insufficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Renal Insufficiency Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Renal Insufficiency Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Renal Insufficiency Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Renal Insufficiency Treatment Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Renal Insufficiency Treatment Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Renal Insufficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Renal Insufficiency Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Renal Insufficiency Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Renal Insufficiency Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Renal Insufficiency Treatment Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Renal Insufficiency Treatment Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Nikkiso Company Details
 Table 48. Nikkiso Business Overview
 Table 49. Nikkiso Renal Insufficiency Treatment Product
 Table 50. Nikkiso Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 51. Nikkiso Recent Development
 Table 52. Fresenius Company Details
 Table 53. Fresenius Business Overview
 Table 54. Fresenius Renal Insufficiency Treatment Product
 Table 55. Fresenius Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 56. Fresenius Recent Development
 Table 57. Baxter Company Details
 Table 58. Baxter Business Overview
 Table 59. Baxter Renal Insufficiency Treatment Product
 Table 60. Baxter Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 61. Baxter Recent Development
 Table 62. Nipro Company Details
 Table 63. Nipro Business Overview
 Table 64. Nipro Renal Insufficiency Treatment Product
 Table 65. Nipro Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 66. Nipro Recent Development
 Table 67. B. Braun Company Details
 Table 68. B. Braun Business Overview
 Table 69. B. Braun Renal Insufficiency Treatment Product
 Table 70. B. Braun Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 71. B. Braun Recent Development
 Table 72. Medtronic Company Details
 Table 73. Medtronic Business Overview
 Table 74. Medtronic Renal Insufficiency Treatment Product
 Table 75. Medtronic Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 76. Medtronic Recent Development
 Table 77. AstraZeneca Company Details
 Table 78. AstraZeneca Business Overview
 Table 79. AstraZeneca Renal Insufficiency Treatment Product
 Table 80. AstraZeneca Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 81. AstraZeneca Recent Development
 Table 82. JMS Co. Ltd. Company Details
 Table 83. JMS Co. Ltd. Business Overview
 Table 84. JMS Co. Ltd. Renal Insufficiency Treatment Product
 Table 85. JMS Co. Ltd. Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 86. JMS Co. Ltd. Recent Development
 Table 87. Cantel Medical Company Details
 Table 88. Cantel Medical Business Overview
 Table 89. Cantel Medical Renal Insufficiency Treatment Product
 Table 90. Cantel Medical Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 91. Cantel Medical Recent Development
 Table 92. Asahi Kasei Medical Co., Ltd. Company Details
 Table 93. Asahi Kasei Medical Co., Ltd. Business Overview
 Table 94. Asahi Kasei Medical Co., Ltd. Renal Insufficiency Treatment Product
 Table 95. Asahi Kasei Medical Co., Ltd. Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 96. Asahi Kasei Medical Co., Ltd. Recent Development
 Table 97. Braun Melsungen AG Company Details
 Table 98. Braun Melsungen AG Business Overview
 Table 99. Braun Melsungen AG Renal Insufficiency Treatment Product
 Table 100. Braun Melsungen AG Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 101. Braun Melsungen AG Recent Development
 Table 102. DaVita Company Details
 Table 103. DaVita Business Overview
 Table 104. DaVita Renal Insufficiency Treatment Product
 Table 105. DaVita Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 106. DaVita Recent Development
 Table 107. Becton Dickinson and Company Company Details
 Table 108. Becton Dickinson and Company Business Overview
 Table 109. Becton Dickinson and Company Renal Insufficiency Treatment Product
 Table 110. Becton Dickinson and Company Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 111. Becton Dickinson and Company Recent Development
 Table 112. dialifegroup Company Details
 Table 113. dialifegroup Business Overview
 Table 114. dialifegroup Renal Insufficiency Treatment Product
 Table 115. dialifegroup Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 116. dialifegroup Recent Development
 Table 117. Isopure Corp Company Details
 Table 118. Isopure Corp Business Overview
 Table 119. Isopure Corp Renal Insufficiency Treatment Product
 Table 120. Isopure Corp Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 121. Isopure Corp Recent Development
 Table 122. Diaverum Company Details
 Table 123. Diaverum Business Overview
 Table 124. Diaverum Renal Insufficiency Treatment Product
 Table 125. Diaverum Revenue in Renal Insufficiency Treatment Business (2020-2025) & (US$ Million)
 Table 126. Diaverum Recent Development
 Table 127. Research Programs/Design for This Report
 Table 128. Key Data Information from Secondary Sources
 Table 129. Key Data Information from Primary Sources
 Table 130. Authors List of This Report


List of Figures
 Figure 1. Renal Insufficiency Treatment Picture
 Figure 2. Global Renal Insufficiency Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Renal Insufficiency Treatment Market Share by Type: 2024 VS 2031
 Figure 4. Dialysis Features
 Figure 5. Medication Features
 Figure 6. Kidney Transplantation Features
 Figure 7. Global Renal Insufficiency Treatment Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Renal Insufficiency Treatment Market Share by Application: 2024 VS 2031
 Figure 9. Hospital Case Studies
 Figure 10. Clinics Case Studies
 Figure 11. Research and Academic Institutes Case Studies
 Figure 12. Renal Insufficiency Treatment Report Years Considered
 Figure 13. Global Renal Insufficiency Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 14. Global Renal Insufficiency Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 15. Global Renal Insufficiency Treatment Market Share by Region: 2024 VS 2031
 Figure 16. Global Renal Insufficiency Treatment Market Share by Players in 2024
 Figure 17. Global Top Renal Insufficiency Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Renal Insufficiency Treatment as of 2024)
 Figure 18. The Top 10 and 5 Players Market Share by Renal Insufficiency Treatment Revenue in 2024
 Figure 19. North America Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. North America Renal Insufficiency Treatment Market Share by Country (2020-2031)
 Figure 21. United States Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Canada Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Europe Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Renal Insufficiency Treatment Market Share by Country (2020-2031)
 Figure 25. Germany Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. France Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. U.K. Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Italy Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Russia Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Nordic Countries Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Asia-Pacific Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Renal Insufficiency Treatment Market Share by Region (2020-2031)
 Figure 33. China Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Japan Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. South Korea Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Southeast Asia Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. India Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Australia Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Latin America Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Renal Insufficiency Treatment Market Share by Country (2020-2031)
 Figure 41. Mexico Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Brazil Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Middle East & Africa Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Renal Insufficiency Treatment Market Share by Country (2020-2031)
 Figure 45. Turkey Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Saudi Arabia Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. UAE Renal Insufficiency Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Nikkiso Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 49. Fresenius Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 50. Baxter Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 51. Nipro Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 52. B. Braun Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 53. Medtronic Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 54. AstraZeneca Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 55. JMS Co. Ltd. Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 56. Cantel Medical Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 57. Asahi Kasei Medical Co., Ltd. Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 58. Braun Melsungen AG Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 59. DaVita Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 60. Becton Dickinson and Company Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 61. dialifegroup Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 62. Isopure Corp Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 63. Diaverum Revenue Growth Rate in Renal Insufficiency Treatment Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Renal Therapeutic Market Research Report 2025
Global End Stage Kidney Disease Market Research Report 2024
Global Kidney Renal Fibrosis Treatment Market Insights Forecast to 2030
Chronic Kidney Disease CKD Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Renal Diseases Drug Market Insights Forecast to 2030
Global End Stage Renal Disease Market Research Report 2024
Global End Stage Renal Disease ESRD Treatment Market Research Report 2025
Renal Anemia Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Renal Fibrosis Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Kidney Medicine Market Insights Forecast to 2030
Global Chronic Kidney Disease Medication Market Research Report 2024
End Stage Renal Disease ESRD Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global CKD and ESRD Treatment Market Research Report 2025
Nephrology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Kidney Fibrosis Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Renal Biomarkers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Chronic Kidney Disease Treatment Market Research Report 2025
Global Acute Kidney Injury Treatment Market Insights Forecast to 2030
End Stage Renal Disease Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global End Stage Renal Disease ESRD Device Market Research Report 2024

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Z7671
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10V14317
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10O5919
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-4I19963
Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions